[Form 4] TrueBlue, Inc. Insider Trading Activity

Rhea-AI Filing Summary

TrueBlue, Inc. (TBI) insider sale by CEO — The CEO and President, Owen Taryn R, reported a sale of 2,472 shares of common stock on 10/02/2025 at a reported price of $5.62 per share. After the sale, the filing shows 412,460 shares beneficially owned outright. The Form 4 was signed on 10/06/2025 by an attorney-in-fact. No derivative transactions or additional remarks were disclosed in the filing.

Positive

• Substantial residual ownership remains at 412,460 shares after the sale
• Transaction was disclosed promptly on a Form 4 signed 10/06/2025

Negative

• Executive sale may be perceived negatively by some investors despite small size
• No explanatory remarks were provided to clarify the reason for the sale

Insights

Corporate Governance Analyst

CEO sale reduces direct holdings but leaves substantial ownership.

The filing documents a routine open-market sale of 2,472 shares at $5.62 on 10/02/2025 by the CEO and President, leaving 412,460 shares owned directly. Such transactions by executives are common for diversification or liquidity and the remaining stake remains large.

The primary risk is signaling: investors sometimes interpret insider sales as reduced confidence, though no additional context or pattern is provided. Monitor subsequent Form 4 filings or scheduled trading plans for clear trends over the next 3-6 months.

Equity Markets Specialist

Small sale size relative to total holdings implies limited market impact.

The transacted amount (2,472 shares at $5.62) is small versus the reported post-transaction holding of 412,460 shares, so market liquidity and valuation effects should be minimal. No derivatives or planned-sale codes are indicated that would alter dilution or future supply.

Short-term items to watch include additional Section 16 filings and any 10b5-1 plan disclosures within the next quarter that would clarify intent.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Owen Taryn R

(Last) (First) (Middle)

1015 A STREET

(Street)

TACOMA WA 98402

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2025		F		2,472	D	$5.62	412,460	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Todd N. Gilman, Attorney-in-fact	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the TrueBlue (TBI) Form 4 filed on 10/06/2025 report?

It reported that CEO Owen Taryn R sold 2,472 shares on 10/02/2025 at $5.62 per share and retained 412,460 shares beneficially.

How many shares does TBI CEO Owen own after the reported sale?

The filing shows 412,460 shares beneficially owned following the reported transaction.

Was the sale executed under a prearranged trading plan for TBI?

No code or remark indicating a 10b5-1 plan or deemed execution date was disclosed on the form.

Does the Form 4 for TBI include any derivative transactions or options?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned in this filing.

Who signed the Form 4 for the TrueBlue insider filing?

The Form 4 was signed by Todd N. Gilman, Attorney-in-fact on 10/06/2025.